Becton Dickinson (NYSE: BDX) reported Q1 EPS of $2.68, $0.28 better than the analyst estimate of $2.40. Revenue for the quarter came in at $4.7 billion versus the consensus estimate of $4.73 billion.

GUIDANCE:

Becton Dickinson sees FY 2024 EPS of $12.82-$13.06. Becton Dickinson sees Q2 2024 revenue of $20.2-20.4 billion.

Total currency-neutral revenue growth is now expected to be 4.75% to 5.5% compared to 4.5% to 5.5% previously. Total currency-neutral revenue growth continues to reflect a negative impact of approximately 75 basis points from the impact of the Surgical Instrumentation platform divestiture.
Based on current rates, foreign exchange represents a reduction of approximately 25 basis points to total company revenue growth.

For earnings history and earnings-related data on Becton Dickinson (BDX) click here.